Cargando…

Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors

OBJECTIVES: Liver disease is a major cause of morbidity and mortality in sub-Saharan Africa, but its prevalence, distribution and aetiology have not been well characterised. We therefore set out to examine liver function tests (LFTs) and liver fibrosis scores in a rural African population. DESIGN: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Hara, Geraldine, Mokaya, Jolynne, Hau, Jeffrey P, Downs, Louise O, McNaughton, Anna L, Karabarinde, Alex, Asiki, Gershim, Seeley, Janet, Matthews, Philippa C, Newton, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170602/ https://www.ncbi.nlm.nih.gov/pubmed/32234740 http://dx.doi.org/10.1136/bmjopen-2019-032890

Ejemplares similares

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

The role of hepatic microenvironment in hepatic fibrosis development
por: Meng, Ying, et al.
Publicado: (2022)

Economic burden of cirrhosis in Catalonia: a population-based analysis
por: Miquel, Mireia, et al.
Publicado: (2018)

Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
por: Ratib, Sonia, et al.
Publicado: (2017)

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
por: Sulyok, Mihály, et al.
Publicado: (2017)

Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
por: Xiao, Shiyu, et al.
Publicado: (2023)

Global, regional and national burden of gastroesophageal reflux disease, 1990–2019: update from the GBD 2019 study
por: Zhang, Decai, et al.
Publicado: (2022)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
por: Chen, Qiushi, et al.
Publicado: (2019)

Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
por: Jin, Young-Joo, et al.
Publicado: (2014)

Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
por: Erman, Aysegul, et al.
Publicado: (2019)

Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
por: Cheng, Wenli, et al.
Publicado: (2023)

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
por: Poynard, Thierry, et al.
Publicado: (2015)

Prevalence of liver fibrosis and associated risk factors in the Korean general population: a retrospective cross-sectional study
por: Nah, Eun-Hee, et al.
Publicado: (2021)

Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
por: Park, Jung Gil, et al.
Publicado: (2020)

Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study
por: Coelho, Juliana Moraes, et al.
Publicado: (2020)

Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD)? protocol for a feasibility randomised controlled trial
por: Subhani, Mohsan, et al.
Publicado: (2021)

A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice
por: Zheng, Shumei, et al.
Publicado: (2022)

The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018
por: Liu, Jie, et al.
Publicado: (2022)

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
por: Peng, Xiongqun, et al.
Publicado: (2023)

Feasibility and acceptability of a primary care liver fibrosis testing pathway centred on the diabetes annual review: PRELUDE1 prospective cohort study protocol
por: Brindley, James Hallimond, et al.
Publicado: (2023)

Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017–2018
por: Ji, Yuan, et al.
Publicado: (2023)

Identification of patients with type 2 diabetes with non-alcoholic fatty liver disease who are at increased risk of progressing to advanced fibrosis: a cross-sectional study
por: Mettananda, Chamila, et al.
Publicado: (2023)

Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion-dependent beta thalassaemia: a cross-sectional study
por: Padeniya, Padmapani, et al.
Publicado: (2022)

RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial
por: Jopson, Laura, et al.
Publicado: (2015)

Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
por: Amin, Neeta B, et al.
Publicado: (2022)

Effectiveness of intravenous albumin therapy to prevent spontaneous bacterial peritonitis, renal dysfunction and death in adults with cirrhosis: a protocol for a systematic review
por: Härmälä, Suvi, et al.
Publicado: (2019)

Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case–control study
por: Katsidzira, Leolin, et al.
Publicado: (2020)

Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis
por: Härmälä, Suvi, et al.
Publicado: (2019)

Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol
por: Nieto, T, et al.
Publicado: (2016)

Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
por: Jarvis, Helen, et al.
Publicado: (2022)

Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study
por: Markby, Jessica, et al.
Publicado: (2021)

ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial
por: China, Louise, et al.
Publicado: (2016)

Incidence of household transmission of acute gastroenteritis (AGE) in a primary care sentinel network (1992–2017): cross-sectional and retrospective cohort study protocol
por: de Lusignan, Simon, et al.
Publicado: (2018)

PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial
por: Woodhouse, Charlotte Alexandra, et al.
Publicado: (2019)

Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults
por: Everitt, Hazel, et al.
Publicado: (2015)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

A Study of Knowledge, Experience, and Beliefs About Hepatitis B Virus (HBV) Infection in South Western Uganda
por: Mugisha, Joseph, et al.
Publicado: (2019)

ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial
por: China, Louise, et al.
Publicado: (2018)

Lived experience of dietary change among Chinese colorectal cancer survivors in Hong Kong: A qualitative study
por: Wong, Janet Yuen Ha, et al.
Publicado: (2021)

Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial)
por: O'Toole, Saoirse, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c6v27pv32em0d8u6tse6l55dhh